Tags

Type your tag names separated by a space and hit enter

Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations.
Int J Antimicrob Agents. 2006 Feb; 27(2):97-101.IJ

Abstract

The Surviving Sepsis Campaign is the first international, multiorganisation, multidisciplinary attempt to reduce the appalling morbidity and mortality related to sepsis. Under the auspices of the campaign, guidelines have been published that cover more than 50 aspects of care of the septic patient. Campaign guidelines on antimicrobial therapy cover very general aspects of antibiotic policy and are mostly supported by expert opinion rather than randomised controlled trials. However, these 'common sense' recommendations on antibiotic therapy have been included in this review. The core areas of the Surviving Sepsis Campaign guidelines have been crystallised into resuscitation and management 'bundles'. This review focuses on the most important clinical trials that form the basis of these core guidelines.

Authors+Show Affiliations

Gilbert Bain Hospital, South Road, Lerwick, Shetland ZE1 0TG, UK. brodyn.poulton@shb.shetland.scot.nhs.uk

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16417989

Citation

Poulton, B. "Advances in the Management of Sepsis: the Randomised Controlled Trials Behind the Surviving Sepsis Campaign Recommendations." International Journal of Antimicrobial Agents, vol. 27, no. 2, 2006, pp. 97-101.
Poulton B. Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations. Int J Antimicrob Agents. 2006;27(2):97-101.
Poulton, B. (2006). Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations. International Journal of Antimicrobial Agents, 27(2), 97-101.
Poulton B. Advances in the Management of Sepsis: the Randomised Controlled Trials Behind the Surviving Sepsis Campaign Recommendations. Int J Antimicrob Agents. 2006;27(2):97-101. PubMed PMID: 16417989.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations. A1 - Poulton,B, Y1 - 2006/01/18/ PY - 2006/1/19/pubmed PY - 2006/4/11/medline PY - 2006/1/19/entrez SP - 97 EP - 101 JF - International journal of antimicrobial agents JO - Int J Antimicrob Agents VL - 27 IS - 2 N2 - The Surviving Sepsis Campaign is the first international, multiorganisation, multidisciplinary attempt to reduce the appalling morbidity and mortality related to sepsis. Under the auspices of the campaign, guidelines have been published that cover more than 50 aspects of care of the septic patient. Campaign guidelines on antimicrobial therapy cover very general aspects of antibiotic policy and are mostly supported by expert opinion rather than randomised controlled trials. However, these 'common sense' recommendations on antibiotic therapy have been included in this review. The core areas of the Surviving Sepsis Campaign guidelines have been crystallised into resuscitation and management 'bundles'. This review focuses on the most important clinical trials that form the basis of these core guidelines. SN - 0924-8579 UR - https://www.unboundmedicine.com/medline/citation/16417989/Advances_in_the_management_of_sepsis:_the_randomised_controlled_trials_behind_the_Surviving_Sepsis_Campaign_recommendations_ DB - PRIME DP - Unbound Medicine ER -